Video

Q&A With W. Frank Peacock IV From Baylor College of Medicine: Taking a Closer Look at Benefits and Risks of Rivaroxaban

Author(s):

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

W. Frank Peacock IV, MD, from the Baylor College of Medicine discussed this balancing act for doctors during the European Society of Cardiology's annual congress in London.

Patients who take oral anticoagulants are always made aware of potential bleeding risks that come with the medication. How doctors approach those risks and move forward can determine a patient's understanding of their condition in their daily lives.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.